Importantly, we observed low expression of these molecules in both groups at all time points, similar to levels found in healthy individuals and below those observed in COVID-19 patients (>40% of CD4+ and CD8+ T-cells) by Diao et al. This evidence concerns the gene CD8A and COVID-19.